Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease

NCT07020026 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: [18F]PI-2620

Sponsor

Michael J. Fox Foundation for Parkinson's Research

Collaborators

[object Object]